Figure 3
Kaplan-Meier survival curves of relapse-free survival according to CD34+ myeloblasts levels. The RFS probabilities of ≤0.18% group, 0.19–0.38% group, 0.39–0.59% group and >0.60% group were not significantly different.
Figure 3 | Scientific Reports
